Decoding Pancreatic Cancer: The Role of Testing and Genetics

Thank you to Arcus Biosciences and Revolution Medicines for sponsoring this webinar.

We want to hear your feedback. Please take 1 minute to fill out this survey to win a prize. The winner will be chosen by March 31st.
https://www.surveymonkey.com/r/decoding

Jenny Pagel-Guile: Welcome and NPF Updates

Moderator:
Eileen O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers
Co-Director Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Chair, Human Research Protection Program & IRB
Attending Physician, Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
National Pancreas Foundation Board of Directors, Chair

(00:04:35) Overview of Pancreatic Cancer
Efrat Dotan, MD
Executive Medical Director,
Ann B Barshinger Cancer Institute, Lancaster General Health Penn Medicine

(00:18:32) Genetic testing for Pancreatic Cancer Surveillance: Ready for Prime Time?
David Whitcomb, MD
Emeritus Professor of Medicine, Cell Biology & Physiology, Human Genetics
Chief, Division of Gastroenterology, Hepatology and Nutrition (1999-2016), University of Pittsburgh and UPMC
Adjunct Professor of Biomedical Engineering, Carnegie Mellon University
Co-Founder and CSO, Ariel Precision Medicine

(00:38:43) Decoding Pancreatic Cancer: The Role of Testing and Genetics - Treatment Implications
Eileen O’Reilly, MD

(00:54:54) Patient Advocate - Kara Murphy

(1:00:10) Panel Q&A